Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy

Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy

BackgroundHypertrophic cardiomyopathy (HCM) is associated with an increased risk of adverse cardiac events. Beyond classic risk factors, relative myocardial ischaemia and succeeding myocardial alterations, which can be detected using either contrast agents or parametric mapping in cardiovascular mag...

Full description

Bibliographic Details
Main Authors: Robert Manka, Mareike Gastl, Hatem Alkadhi, Christiane Gruner, Karin Labucay, Alexander Gotschy, Jochen Von Spiczak, Malgorzata Polacin, Florian Boenner, Malte Kelm, Frank Ruschitzka, Sebastian Kozerke
Format: Article
Language:English
Published: BMJ Publishing Group 2020-06-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/7/1/e001152.full

Internet

https://openheart.bmj.com/content/7/1/e001152.full

Similar Items